- Home
- IREN vs SNN Comparison
IREN vs SNN Comparison
Compare IREN & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IREN | SNN |
|---|---|---|
| Founded | 2018 | 1856 |
| Country | Australia | United Kingdom |
| Employees | N/A | 17349 |
| Industry | EDP Services | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1B | 13.9B |
| IPO Year | 2021 | 1999 |
Fundamental Metrics
Financial Performance| Metric | IREN | SNN |
|---|---|---|
| Price | $58.07 | $32.76 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 4 |
| Target Price | ★ $71.60 | $32.83 |
| AVG Volume (30 Days) | ★ 32.9M | 778.5K |
| Earning Date | 02-11-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 2.24% |
| EPS Growth | N/A | ★ 59.91 |
| EPS | ★ 1.99 | 0.56 |
| Revenue | $688,554,000.00 | ★ $5,944,000,000.00 |
| Revenue This Year | $137.51 | $7.71 |
| Revenue Next Year | $126.13 | $5.23 |
| P/E Ratio | $29.08 | ★ $28.63 |
| Revenue Growth | ★ 234.97 | 5.35 |
| 52 Week Low | $5.13 | $23.91 |
| 52 Week High | $76.87 | $38.79 |
Technical Indicators
Market Signals| Indicator | IREN | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 69.46 | 46.65 |
| Support Level | $50.75 | $31.89 |
| Resistance Level | $48.30 | $34.13 |
| Average True Range (ATR) | 3.92 | 0.62 |
| MACD | 1.87 | -0.04 |
| Stochastic Oscillator | 98.81 | 38.79 |
Price Performance
Historical ComparisonAbout IREN Iris Energy Limited
IREN Ltd is engaged in data center business powering the future of Bitcoin, AI and beyond utilizing renewable energy. Bitcoin mining operations generate revenue by earning Bitcoin through a combination of Block rewards and transaction fees from the operation of its Bitcoin miners and exchanging these Bitcoin for fiat currencies such as USD or CAD.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.